 |
 |
| CEO Thomas Braun and the Verisante team with the commercial prototype of the "Core" Raman scanner, designed for lung cancer screening. A version of this equipment will be used in the UK clinical trial to scan brain tissue. Credit: Verisante via Facebook. |
| © 2024 SPIE Europe |
|
